SCHEMBL307938

SCHEMBL307938

Cc1ccc(C=NS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.78
POLB P06746 2/20 0.78
LMNA P02545 2/20 0.59
GAA P10253 2/20 0.59
KMT2A Q03164 3/20 0.56
ATM Q13315 1/20 0.54
PTGS2 P35354 2/20 0.53
CA12 O43570 2/20 0.53
CA2 P00918 2/20 0.53
CA9 Q16790 2/20 0.53
PTGS1 P23219 1/20 0.53
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
F2 P00734 2/20 0.48
PRSS1 P07477 2/20 0.48
PRSS2 P07478 2/20 0.48
PRSS3 P35030 2/20 0.48
MEN1 O00255 2/20 0.47
TLR9 Q9NR96 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073012 1.00 ALDH1A1 (0.78) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL16802983 1.00 ALDH1A1 (0.78) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL12444230 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL10047321 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL12444212 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL12516171 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL10073008 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL10047339 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL10047332 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A
SCHEMBL10073010 0.91 ALDH1A1 (0.68) ALDH1A1POLBLMNAGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2503984-B1 SULFONIMINES AS BLEACHING ACTIVATORS HENKEL AG & CO KGAA (DE) 2017-11-08 EP disclosed
WO-2015086793-A1 POLYMER SUPPORTED PHOSPHORIC ACIDS AND USE THEREOF AS CATALYSTS IN THE PREPARATION OF 3-INDOLYLMETHANAMINES FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ICIQ) (ES) 2015-06-18 WO disclosed
EP-2883879-A1 Polymer supported phosphoric acids and use thereof as catalysts in the preparation of 3-indolylmethanamines Fundació Institut Català d'Investigació Química (ES) 2015-06-17 EP disclosed
US-8815935-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-08-26 US disclosed
US-20130102639-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-04-25 US disclosed
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-21 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed
WO-2010014054-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-04 WO disclosed
CN-101431996-A Inhibitors of protein prenyltransferases UNIV CALIFORNIA (US) 2009-05-13 CN disclosed
EP-2007383-A2 INHIBITORS OF PROTEIN PRENYLTRANSFERASES The Regents of the University of California (US) 2008-12-31 EP disclosed
WO-2007111948-A2 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102639-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES RABGGTA, FNTA, RABGGTB ALDH1A1 2160/4885POLB 3212/4885LMNA 3093/4885
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB ALDH1A1 1074/4885POLB 2318/4885LMNA 2288/4885
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES RABGGTA, FNTA, RABGGTB ALDH1A1 2160/4885POLB 3212/4885LMNA 3093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.